Discover how FDA, NIH and Congress are fast tracking alternatives to animal testing—and how Organ on a Chip technology is reshaping drug development.| Emulate
Featuring articles on aspirin’s murky origins, scaling proteomics, and the history of fermentation.| www.asimov.press
Hopkins expert Thomas Hartung discusses NIH announcement that it will no longer consider grant proposals that do not include alternative testing models| The Hub
New initiative aims to reduce use of animals in NIH-funded research.| National Institutes of Health (NIH)
This blog explores the landscape of NAMs, explains how they can be used synergistically, and highlights the key factors driving their recent momentum.| Emulate
Cambridge-based biotechnology company Parallel Bio has closed a $21 million Series A funding round led by AIX Ventures.| Drug Discovery and Development
